SCHEMBL8375832

SCHEMBL8375832

CCOC(=O)/C(Br)=C(\Br)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.51
GSK3B P49841 2/20 0.46
PTPN1 P18031 1/20 0.46
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
EPHX2 P34913 1/20 0.43
PPARG P37231 1/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 1/20 0.43
MAOB P27338 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
GPR35 Q9HC97 1/20 0.42
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375834 1.00 NPSR1 (0.51) NPSR1GSK3BPTPN1CES2CES1
SCHEMBL859597 0.81 CES2 (0.60) NPSR1GSK3BPTPN1CES2CES1
SCHEMBL8375792 0.80 SMN1; SMN2 (0.50) GSK3BCES2CES1MAPTALDH1A1
SCHEMBL8375797 0.80 SMN1; SMN2 (0.50) GSK3BCES2CES1MAPTALDH1A1
SCHEMBL1054614 0.79 ALDH1A1 (0.56) NPSR1MAPTALDH1A1KMT2AKDM4E
SCHEMBL11821119 0.79 ALDH1A1 (0.56) NPSR1MAPTALDH1A1KMT2AKDM4E
SCHEMBL840765 0.78 NPSR1 (0.54) NPSR1GSK3BPTPN1CES2CES1
SCHEMBL668192 0.77 CA12 (0.61) NPSR1CES2CES1MAPTKMT2A
SCHEMBL23332553 0.77 NPSR1 (0.52) NPSR1GSK3BPTPN1CES2CES1
SCHEMBL4478898 0.77 NPSR1 (0.52) NPSR1GSK3BPTPN1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed